The last time I wrote about Centessa Pharmaceuticals plc (NASDAQ:CNTA), it was in a Seeking Alpha article entitled “Centessa ...
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback